What diagnostic workup and case sheet should be prepared for an adult with a one‑month history of urticaria (hives) and lip angioedema associated with acute hepatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Case Sheet for Urticaria with Lip Angioedema and Acute Hepatitis

For an adult presenting with one-month history of hives and lip swelling associated with acute hepatitis, this represents chronic urticaria (>6 weeks) with angioedema, and the hepatitis is likely a concurrent viral infection rather than the primary cause of the chronic urticarial symptoms.

Clinical Presentation

Chief Complaint

  • Urticaria (hives) for 1 month
  • Lip angioedema for 1 month
  • Acute hepatitis (concurrent)

History of Present Illness

Document the following specific details:

Urticaria characteristics:

  • Duration of individual wheals (ordinary urticaria: 2-24 hours; if >24 hours, suspect urticarial vasculitis) 1
  • Timing and frequency of episodes
  • Presence of pruritus
  • Triggers identified (physical stimuli, foods, medications, stress, overheating, alcohol) 1

Angioedema characteristics:

  • Location (lips, face, tongue, throat)
  • Duration (can persist up to 72 hours, unlike wheals) 2
  • Airway involvement or difficulty breathing
  • Associated abdominal pain

Hepatitis presentation:

  • Jaundice onset and duration
  • Dark urine, pale stools
  • Fever, malaise, fatigue
  • Right upper quadrant pain
  • Nausea, vomiting, anorexia

Medication History

  • Critical: ACE inhibitors (avoid in angioedema without wheals, use with caution if angioedema present) 1
  • NSAIDs, aspirin, codeine (can worsen urticaria) 1
  • Recent antibiotics, antivirals
  • Any new medications in past 2 months

Past Medical History

  • Previous episodes of urticaria or angioedema
  • Autoimmune diseases (thyroid disease, lupus)
  • Chronic liver disease
  • Atopic conditions
  • Thrombosis history (relevant for treatment options) 1

Social History

  • Illicit drug use (hepatitis risk)
  • Sexual history (hepatitis B risk)
  • Travel history
  • Occupational exposures
  • Recent food consumption (foodborne hepatitis A outbreaks) 3

Physical Examination

Dermatologic

  • Distribution and morphology of wheals
  • Presence of angioedema (lips, periorbital, extremities)
  • Duration observation of individual lesions
  • Dermographism testing
  • Signs suggesting urticarial vasculitis: purpura, hyperpigmentation, residual marks

General

  • Vital signs including temperature
  • Icteric sclera and skin
  • Hepatomegaly, right upper quadrant tenderness
  • Splenomegaly
  • Lymphadenopathy
  • Joint examination (arthritis in Caroli's triad with hepatitis) 4
  • Edema (pretibial, periorbital)

Diagnostic Workup

Essential Laboratory Tests

For Chronic Urticaria with Angioedema (>6 weeks):

Since this is chronic urticaria (1 month = 4 weeks, approaching chronic), perform screening profile for nonresponders 1:

  • Complete blood count with differential (detect eosinophilia from helminth infections, leucopenia from SLE) 1
  • Erythrocyte sedimentation rate (normal in chronic ordinary urticaria; elevated in urticarial vasculitis and autoinflammatory syndromes) 1
  • Thyroid function tests and thyroid autoantibodies (especially if autoimmune etiology suspected) 1
  • Serum C4 level (initial screening for hereditary/acquired C1 inhibitor deficiency in angioedema without wheals) 1
    • If C4 low (<30% mean normal): proceed to C1 inhibitor quantitative and functional assays 1
    • C1q level (reduced in acquired C1 inhibitor deficiency) 1

For Acute Hepatitis:

  • Hepatitis A IgM (acute infection marker; urticaria described in prodromic stage) 3, 4
  • Hepatitis B surface antigen, core antibody IgM (acute hepatitis B commonly associated with urticaria) 4
  • Hepatitis C antibody and HCV RNA (rare but reported with urticaria) 4
  • ALT, AST (liver injury markers)
  • Total and direct bilirubin
  • Alkaline phosphatase, GGT
  • Albumin, INR (synthetic function)
  • Complete metabolic panel (assess renal function; acute renal failure can complicate hepatitis A) 5

Additional Tests Based on Clinical Suspicion:

  • Antinuclear antibodies (if autoimmune etiology suspected; can be positive in hepatitis A with extrahepatic manifestations) 5
  • Complement C3 and C4 (if urticarial vasculitis suspected) 1
  • Autologous serum skin test (ASST) (if autoimmune urticaria suspected and center has experience) 1

Conditional Investigations

If wheals last >24 hours:

  • Lesional skin biopsy (essential to confirm urticarial vasculitis: leucocytoclasia, endothelial damage, perivascular fibrin, red cell extravasation) 1
  • Full vasculitis screen if biopsy positive

If hepatitis etiology unclear:

  • Hepatitis E serology
  • EBV, CMV serology
  • Autoimmune hepatitis panel (ANA, anti-smooth muscle antibody, anti-LKM)
  • Drug-induced liver injury assessment

Assessment and Diagnosis

Primary Diagnoses

  1. Chronic ordinary urticaria with angioedema (duration >6 weeks by presentation)
  2. Acute viral hepatitis (specify type: A, B, or C based on serology)

Clinical Reasoning

Urticaria is commonly observed in the prodromic stage of hepatitis A and B infection 4. However, given the one-month duration, this represents chronic urticaria that may have been triggered by viral hepatitis but has persisted beyond the typical acute phase. Acute urticaria related to viral hepatitis is part of immune-complex deposits and may be associated with arthritis and headache (Caroli's triad) 4.

Important distinction: No convincing evidence exists that hepatitis virus infection causes chronic urticaria 4. The temporal association suggests the hepatitis may have triggered the urticaria, but the chronicity indicates a separate ongoing process.

Differential Diagnoses to Exclude

  • Urticarial vasculitis (if wheals >24 hours)
  • Hereditary or acquired angioedema (if angioedema without wheals predominates)
  • Drug-induced urticaria (NSAIDs, ACE inhibitors)
  • Autoimmune urticaria (30% of chronic spontaneous urticaria) 1
  • Autoinflammatory syndromes (if fever, joint pain, elevated ESR)

Management Plan

Immediate Management

Assess for complications:

  • Airway compromise from angioedema (requires emergency intervention)
  • Hepatic failure signs (encephalopathy, coagulopathy)
  • Acute renal failure (can complicate hepatitis A) 5

Urticaria and Angioedema Treatment

First-line therapy:

  • Second-generation H1 antihistamines (cetirizine, desloratadine, fexofenadine, levocetirizine, loratadine) once daily 1
  • Offer choice of at least two different antihistamines (responses vary between individuals) 1
  • Can increase dose up to 4 times the standard dose if inadequate response (common practice when benefits outweigh risks) 1

Medication precautions:

  • Avoid mizolastine if cardiac disease or QT prolongation present 1
  • Avoid NSAIDs and aspirin (can worsen urticaria) 1
  • Discontinue ACE inhibitors if patient is taking them 1

Second-line options for resistant cases:

  • Add H2 antihistamines
  • Add sedating antihistamine at night
  • Consider antileukotrienes 1

For severe acute exacerbations:

  • Short course oral corticosteroids (restrict to severe acute urticaria or angioedema affecting mouth) 1

Supportive measures:

  • Cooling antipruritic lotions (calamine or 1% menthol in aqueous cream) 1
  • Avoid aggravating factors: overheating, stress, alcohol 1

Hepatitis Management

Supportive care:

  • Rest, adequate hydration
  • Avoid hepatotoxic medications and alcohol
  • Monitor liver function tests weekly initially
  • Assess for complications (coagulopathy, encephalopathy, renal dysfunction)

Specific considerations:

  • Regular monitoring for hepatic inflammation if anabolic steroids considered for C1 inhibitor deficiency 1
  • Liver function tests recommended if tranexamic acid used long-term 1

Follow-up Plan

Initial follow-up (1-2 weeks):

  • Reassess urticaria activity and angioedema
  • Review hepatitis serology results
  • Monitor liver and renal function
  • Adjust antihistamine dose if needed

Ongoing monitoring:

  • Disease activity assessment at every visit using validated tools
  • Hepatitis resolution (typically 2-8 weeks for hepatitis A)
  • Urticaria prognosis: 50% of patients with wheals and angioedema have active disease after 5 years (poorer outlook than wheals alone) 1

Patient Education

Urticaria counseling:

  • Cause unlikely to be found in most cases
  • Prognosis for eventual recovery is excellent for ordinary urticaria 1
  • Identify and avoid triggers when possible
  • Cover bleeding wounds to prevent blood contact (hepatitis precaution) 6

Hepatitis precautions:

  • Do not donate blood or organs
  • Avoid sharing toothbrushes, razors, dental equipment
  • Clean blood spills with 1:9 bleach solution wearing gloves 6
  • Counsel on transmission prevention based on hepatitis type

Prognosis

  • Urticaria with angioedema: Over 50% still have active disease after 5 years 1
  • Hepatitis A: Self-limited, generally good prognosis
  • Hepatitis B/C: Variable depending on chronicity and complications

Common Pitfalls to Avoid

  1. Do not perform extensive hepatitis screening for chronic urticaria alone - no convincing evidence links hepatitis C to chronic urticaria; systematic investigations not cost-effective 4
  2. Do not assume hepatitis is causing chronic urticaria - temporal association does not equal causation beyond acute phase
  3. Do not miss urticarial vasculitis - biopsy if wheals last >24 hours 1
  4. Do not overlook C1 inhibitor deficiency - check C4 in angioedema without wheals 1
  5. Do not continue ACE inhibitors - contraindicated in angioedema 1
  6. Do not use prolonged corticosteroids - restrict to short courses for severe cases 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.